


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.13%
+0.69%
-2.08%
+0.82%
-8.52%
HCSG
Healthcare Services Group
$18.71
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
HCSG Price Performance
$17.26 (+8.40%)
$16.54 (+13.12%)
$13.2 (+41.74%)
$11.6 (+61.29%)
HCSG has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

HCSG overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Has a Strong balance sheet
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
HCSG Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HCSG Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is HCSG current stock price?
What are HCSG stock strengths?
What is HCSG Risk Level?
What is HCSG market cap and volume?
What is HCSG current Stock IQ?
Should I buy HCSG stock right now?
Is HCSG a Strong Buy right now?
What does a 'Strong Buy' rating mean for HCSG?
What does a 'Strong Sell' rating mean for HCSG?
What factors influence HCSG's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.13%
+0.69%
-2.08%
+0.82%
-8.52%
HCSG
Healthcare Services Group
Current Price
$18.71
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

HCSG Price Performance
$17.26 (+8.40%)
$16.54 (+13.12%)
$13.2 (+41.74%)
$11.6 (+61.29%)
HCSG Analysts Opinion
HCSG Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Has a Strong balance sheet
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
HCSG Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HCSG Street Sentiment is extremely bullish and have positive views on the near-term outlook
HCSG has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
HCSG Stock IQ
HCSG Latest Analysis
Ambulatory Healthcare Services Market Growth Outlook: CAGR of 5.5% and Value Reaching USD 1336.01 Billion by 2032. is estimated to be valued at USD 918.42 Bn in 2025 and is expected to reach USD 1336.01 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. This expansion is fueled by rising demand for outpatient services continuous advancements in medical technology and a global shift toward more cost-effective healthcare delivery models.
Tue Dec 2, 2025
Friday Sector Leaders: Healthcare Services. The best performing sector as of midday Friday is the Healthcare sector higher by 3.4%. Within that group Align Technology Inc (Symbol: ALGN) and Cooper Companies Inc. (Symbol: COO) are two large stocks leading the way showing a gain of 7.4% and 6.7% respectively. Among he
Fri Nov 21, 2025
Ardent Health (ARDT) Faces Investor Scrutiny Amid Problems Estimating Collection of Accounts Receivable Disclosure Drives Stock Down 33% -- Hagens Berman. SAN FRANCISCO Nov. 19 2025 /PRNewswire/ -- On November 13 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results widely missing consensus EPS estimates and...
Wed Nov 19, 2025
CentralReach Appoints Peter Boumenot as Chief Product Officer. Fort Lauderdale FL Nov. 17 2025 (GLOBE NEWSWIRE) -- a leading provider of Autism and IDD Care software for ABA multidisciplinary and special education today announced the appointment of Peter Boumenot as the company'.s Chief Product Officer. With over 20 years of experience in technology-enabled healthcare services Boumenot has a strong track record of guiding product commercial and operational teams to deliver meaningful change
Mon Nov 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HCSG Stock trends
HCSG Stock performance
HCSG Stock analysis
HCSG investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.